TG Therapeutics
TGTX
TGTX
132 hedge funds and large institutions have $534M invested in TG Therapeutics in 2018 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 36 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.11% more ownership
Funds ownership: 51.07% → 52.17% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $548M → $534M (-$13.9M)
Holders
132
Holding in Top 10
1
Calls
$20.8M
Puts
$8.63M
Top Buyers
| 1 | +$23.8M | |
| 2 | +$11.2M | |
| 3 | +$7.97M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.81M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$4.61M |
Top Sellers
| 1 | -$15.3M | |
| 2 | -$8.57M | |
| 3 | -$5.84M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$3.68M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$3.34M |